pharma · Molluscum Contagiosum · Common Warts (Verruca Vulgaris) · VRCA
Verrica Pharmaceuticals
Verrica Pharmaceuticals patent portfolio — 7 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- West Chester, USA
- Founded
- 2013
- Employees
- 80
- Programs
- 7
- Drugs
- 3
- Patents
- 7
Verrica Pharmaceuticals patents
7 pharmaceutical patents indexed for Verrica Pharmaceuticals. 0 expire within 24 months.
Verrica Pharmaceuticals has 7 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12290651
Devices and methods for the treatment of body surface disorders
granted -
US 12233042
Treatment of cutaneous disorders
granted -
US 12221452
Synthesis of cantharidin
granted -
US 11168091
Quantification and preparation of pharmaceutical grade cantharidin
granted -
US 11147790
Treatment of cutaneous disorders
granted -
US 11052064
Compositions, methods and systems for the treatment of cutaneous disorders
granted -
US 10745413
Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives
granted
Frequently asked questions
How many patents does Verrica Pharmaceuticals have?
7 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Verrica Pharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.